Evidence map›Paper›PMID 32169057›Full record

ArticleBMC cardiovascular disorders2020

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.

Yasuhisa Nakao, Kazuyoshi Suenari, Kohei Yamashiro, Hiroshi Nakagawa, Nobuo Shiode

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC cardiovascular disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yasuhisa NakaoDepartment of Cardiology, Hiroshima Citizens Hiroshima City Hospital, 7-33 Motomachi, Naka-ku, Hiroshima, 730-8515, Japan.
Kazuyoshi SuenariDepartment of Cardiology, Hiroshima Citizens Hiroshima City Hospital, 7-33 Motomachi, Naka-ku, Hiroshima, 730-8515, Japan. suenari@bg7.so-net.ne.jp.
Kohei YamashiroDepartment of Cardiology, Takatsuki General Hospital, Takatsuki, Japan.
Hiroshi NakagawaHeart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Nobuo ShiodeDepartment of Cardiology, Hiroshima Citizens Hiroshima City Hospital, 7-33 Motomachi, Naka-ku, Hiroshima, 730-8515, Japan.
Hiroshima City Asa Citizens Hospital · JPTakatsuki General Hospital · JPUniversity of Oklahoma Health Sciences Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe subcutaneous implantable cardioverter defibrillator (S-ICD) is an alternative to the transvenous implantable cardioverter defibrillator for the prevention of sudden cardiac death. Here, we report a rare case of refractoriness to an S-ICD after frequent therapies for ventricular fibrillation (VF) storms. CASE PRESENTATION: A 24-year-old man underwent a bout of syncope with vomiting and incontinence at home. He was brought to the emergency room and was witnessed to spontaneously go into VF successfully converted by external defibrillation. Previously, he was diagnosed with a type I Brugada electrocardiogram pattern by a pilsicainide administration test in another hospital. Although he had a family history of sudden cardiac death in 3 relatives, including his brother, he was followed closely without any therapies because he had never had an episode of syncope. He was implanted with an S-ICD without any trouble. Seven months later, frequent S-ICD shocks for VF storms occurred. His VF was controlled by using intravenous amiodarone, which was converted to an oral preparation. However, his VF recurred after another 2 months. The analysis of his S-ICD data revealed that 4 consecutive shock deliveries could not terminate his VF and the final shock delivered could fortunately terminate it because of a high defibrillation threshold test (DFT) due to an increasing shock impedance (64 to 90 Ω). First, we performed an epicardial Brugada syndrome ablation and subsequently replaced and repositioned the S-ICD lead from a left to a right parasternal site. After the re-implantation of the S-ICD, the DFT test improved to within normal range. According to the pathological analysis, infiltration of inflammatory cells and extensive fibrosis were confirmed in the subcutaneous tissue around the shock lead and S-ICD body.

conclusionFrequent S-ICD shocks for VF storms might cause various pathological changes around the device and lead to a high DFT.

Indexed as

Catheter AblationDefibrillators, ImplantableHeart RateBrugada SyndromeDevice RemovalElectric CountershockForeign-Body MigrationHumansMaleRecurrenceTreatment FailureVentricular FibrillationYoung AdultBrugada syndromeDefibrillation thresholdS-ICDVentricular fibrillation

Identifiers

PMID32169057
PMCPMC7071569
OpenAlexW3012125308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.